Fusion Cell Markers in Circulating Tumor Cells from Patients with High-Grade Ovarian Serous Carcinoma

Cancer is primarily a disease in which late diagnosis is linked to poor prognosis, and unfortunately, detection and management are still challenging. Circulating tumor cells (CTCs) are a potential resource to address this disease. Cell fusion, an event discovered recently in CTCs expressing carcinom...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruano, Anna Paula Carreta, Gadelha Guimarães, Andrea Paiva, Braun, Alexcia C., Flores, Bianca C. T. C. P., Tariki, Milena Shizue, Abdallah, Emne A., Torres, Jacqueline Aparecida, Nunes, Diana Noronha, Tirapelli, Bruna, de Lima, Vladmir C. Cordeiro, Fanelli, Marcello Ferretti, Colombo, Pierre-Emmanuel, da Costa, Alexandre André Balieiro Anastácio, Alix-Panabières, Catherine, Chinen, Ludmilla Thomé Domingos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740150/
https://www.ncbi.nlm.nih.gov/pubmed/36499015
http://dx.doi.org/10.3390/ijms232314687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740150/
https://www.ncbi.nlm.nih.gov/pubmed/36499015
http://dx.doi.org/10.3390/ijms232314687

Ejemplares similares